Beckman Coulter Plans FDA Submissions in May or June for Troponin Test

Its time estimate is based on the current status of its clinical trial for the test, including site and patient enrolment, and preliminary myocardial infarction incidence rates observed.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.